Cite
HARVARD Citation
Brohl, A. et al. (2016). A phase IB study of ipilimumab with peginterferon alfa-2b in patients with unresectable melanoma. Journal for immunotherapy of cancer. 4 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Brohl, A. et al. (2016). A phase IB study of ipilimumab with peginterferon alfa-2b in patients with unresectable melanoma. Journal for immunotherapy of cancer. 4 (1), p. . [Online].